Dr. Sara Elias, MD Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
Dr. Patricia T Calayag, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Dr. Paul F Gleason, M.D. Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Medicare Enrolled Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
Dr. William S Nelson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Kelly Meghan Mcnally, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 631-988-2111 |
Kristina Martimucci Feldman, DO Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Medicare Enrolled Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8040 Fax: 914-848-8801 |
Dr. Allan B Warshowsky, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 150 Purchase St, Suite 12r, Rye, NY 10580 Phone: 914-967-1630 Fax: 914-967-1624 |
Jackie Xiang, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
Dr. Vanessa Alexy Grano, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Annette L Bond, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Medicare Enrolled Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8040 Fax: 914-848-8041 |
Dr. Heather Hume, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8040 |
Dr. Ranjan Kumar Dasgupta, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Dr. Elizabeth M Legatt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Stephen F Carolan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
Ashley Monroe Pritchard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
Dr. Patricia B Close, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-682-6403 |
Dr. Seema Sharma, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
News Archive
"The world's first major outbreak of Ebola hemorrhagic fever since 2009 has killed at least 14 of 20 people infected in a remote area of midwestern Uganda," the Wall Street Journal reports (Bariyo/McKay, 7/29).
New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.
With a view to increasing the spread of Global Health Partner's shares in connection with one of the company's major shareholders wishing to reduce its shareholding, Avanza Bank was given the assignment of offering 950,000 shares to its depot customers, with a subscription period from 24-30 March 2010.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
When trauma spills the contents of our cell powerhouses, it can evoke a potentially deadly immune response much like a severe bacterial infection.
› Verified 6 days ago